ArticleCureus2025
A Case of Primary Central Nervous System Lymphoma Mimicking a Demyelinating Disorder: From Steroids to Stem Cell Transplant.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: Post-transplant lymphoproliferative disorder mimicking Baló's concentric sclerosis.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary central nervous system lymphoma (PCNSL) is a relatively uncommon and aggressive type of brain malignancy that can achieve long-term remission if it is detected promptly and treatment is initiated on time. However, it can be notorious in its presentation in atypical cases and can disguise itself as multiple other central nervous system (CNS) disorders. In this report, we describe the case of a 60-year-old immunocompetent male presenting with radiographic features, neurological deficits, and partial steroid responsiveness, which were consistent with a demyelinating disease. However, his symptomatic improvement was only transient, which prompted us to perform a biopsy. The biopsy revealed a PCNSL, and he was subsequently started on a high-dose methotrexate, rituximab, and temozolomide regimen, leading to near complete radiological remission. He underwent autologous hematopoietic stem cell transplantation post chemotherapy, which achieved durable remission with significant clinical recovery. This case highlights the risk of misdiagnosis when PCNSL presents with atypical imaging and steroid-induced improvement, while also demonstrating favourable outcomes with timely intervention with combined chemotherapy and stem cell transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.